147 related articles for article (PubMed ID: 36764905)
1. Prevalence of non-alcoholic fatty liver disease in a multicentre cohort of people living with HIV in Spain.
Navarro J; Curran A; Raventós B; García J; Suanzes P; Descalzo V; Álvarez P; Espinosa N; Montes ML; Suárez-García I; Amador C; Muga R; Falcó V; Burgos J;
Eur J Intern Med; 2023 Apr; 110():54-61. PubMed ID: 36764905
[TBL] [Abstract][Full Text] [Related]
2. The impact of integrase inhibitors on steatosis and fibrosis biomarkers in persons with HIV naïve to antiretroviral therapy.
Fernandes SR; Leite AR; Lino R; Guimarães AR; Pineiro C; Serrão R; Freitas P
BMC Infect Dis; 2023 Aug; 23(1):553. PubMed ID: 37620821
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and dynamics of NAFLD-associated fibrosis in people living with HIV in Vienna from first presentation to last follow-up.
Schwarz C; Chromy D; Bauer D; Duong N; Schmidbauer VU; Schwarz M; Mandorfer M; Rieger A; Trauner M; Gschwantler M; Reiberger T
Wien Klin Wochenschr; 2023 Aug; 135(15-16):420-428. PubMed ID: 36576556
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of serological biomarkers for detection of non-alcoholic fatty liver disease (NAFLD) and/or advanced liver fibrosis in people living with HIV.
Yanavich C; Pacheco AG; Cardoso SW; Nunes EP; Chaves U; Freitas G; Santos R; Morata M; Veloso VG; Grinsztejn B; Perazzo H
HIV Med; 2021 Jul; 22(6):445-456. PubMed ID: 33529485
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Characteristics of Nonalcoholic Fatty Liver Disease and Fibrosis in People Living With HIV Monoinfection: A Systematic Review and Meta-analysis.
Kalligeros M; Vassilopoulos A; Shehadeh F; Vassilopoulos S; Lazaridou I; Mylonakis E; Promrat K; Wands JR
Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1708-1722. PubMed ID: 36642292
[TBL] [Abstract][Full Text] [Related]
6. "Dangerous liaisons: NAFLD and liver fibrosis increase cardiovascular risk in HIV".
Cervo A; Sebastiani G; Milic J; Krahn T; Mazzola S; Petta S; Cascio A; Guaraldi G; Mazzola G
HIV Med; 2022 Sep; 23(8):911-921. PubMed ID: 35199429
[TBL] [Abstract][Full Text] [Related]
7. Regional variation in NAFLD prevalence and risk factors among people living with HIV in Europe: a meta-analysis.
Jin D; Jin S; Zhou T; Cui Z; Guo B; Li G; Zhang C
Front Public Health; 2023; 11():1295165. PubMed ID: 38259755
[TBL] [Abstract][Full Text] [Related]
8. Effects of Food Insecurity on Hepatic Steatosis and Fibrosis in People With HIV.
Kardashian A; Lloyd A; Vilar-Gomez E; Naggie S; Sulkowski MS; Woreta T; Lake JE; Crandall H; Loomba R; Wilson LA; Sterling RK; Heath S; Gawrieh S; Chalasani NP; Price JC;
Clin Gastroenterol Hepatol; 2024 Jul; 22(7):1427-1435.e6. PubMed ID: 38582290
[TBL] [Abstract][Full Text] [Related]
9. Indian patients with human immunodeficiency virus infection have high prevalence but mild severity of non-alcoholic fatty liver disease.
De A; Duseja A; Badhala P; Taneja S; Sharma A; Arora S
Diabetes Metab Syndr; 2022 Dec; 16(12):102679. PubMed ID: 36450180
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients.
Vuille-Lessard É; Lebouché B; Lennox L; Routy JP; Costiniuk CT; Pexos C; Giannakis A; Szabo J; Klein MB; Sebastiani G
AIDS; 2016 Nov; 30(17):2635-2643. PubMed ID: 27603289
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, Predictors, and Severity of Lean Nonalcoholic Fatty Liver Disease in Patients Living With Human Immunodeficiency Virus.
Cervo A; Milic J; Mazzola G; Schepis F; Petta S; Krahn T; Lebouche B; Deschenes M; Cascio A; Guaraldi G; Sebastiani G
Clin Infect Dis; 2020 Dec; 71(10):e694-e701. PubMed ID: 32280969
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of liver fibrosis in ageing patients with HIV at risk for non-alcoholic fatty liver disease in Italy and Canada: assessment of a two-tier pathway.
Sebastiani G; Milic J; Gioe C; Al Hinai AS; Cervo A; Lebouche B; Deschenes M; Cascio A; Mazzola G; Guaraldi G
Lancet HIV; 2022 Mar; 9 Suppl 1():S4. PubMed ID: 35304846
[TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes.
Sobhonslidsuk A; Pulsombat A; Kaewdoung P; Petraksa S
Asian Pac J Cancer Prev; 2015; 16(5):1789-94. PubMed ID: 25773826
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and risk factors of metabolic associated fatty liver disease among people living with HIV in China.
Liu D; Shen Y; Zhang R; Xun J; Wang J; Liu L; Steinhart C; Chen J; Lu H
J Gastroenterol Hepatol; 2021 Jun; 36(6):1670-1678. PubMed ID: 33140878
[TBL] [Abstract][Full Text] [Related]
15. Depression is associated with non-alcoholic fatty liver disease among adults in the United States.
Kim D; Yoo ER; Li AA; Tighe SP; Cholankeril G; Harrison SA; Ahmed A
Aliment Pharmacol Ther; 2019 Sep; 50(5):590-598. PubMed ID: 31328300
[TBL] [Abstract][Full Text] [Related]
16. Uncovering the NAFLD burden in people living with HIV from high- and middle-income nations: a meta-analysis with a data gap from Subsaharan Africa.
Manzano-Nunez R; Rivera-Esteban J; Navarro J; Bañares J; Sena E; Schattenberg JM; Lazarus JV; Curran A; Pericàs JM
J Int AIDS Soc; 2023 Mar; 26(3):e26072. PubMed ID: 36924219
[TBL] [Abstract][Full Text] [Related]
17. Different effects of low muscle mass on the risk of non-alcoholic fatty liver disease and hepatic fibrosis in a prospective cohort.
Choe HJ; Lee H; Lee D; Kwak SH; Koo BK
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):260-269. PubMed ID: 36403577
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease and hepatic fibrosis among perinatally HIV-monoinfected Asian adolescents receiving antiretroviral therapy.
Sudjaritruk T; Bunupuradah T; Aurpibul L; Kosalaraksa P; Kurniati N; Sophonphan J; Trinavarat P; Visrutaratna P; Srinakarin J; Chaijitraruch N; Puthanakit T;
PLoS One; 2019; 14(12):e0226375. PubMed ID: 31856189
[TBL] [Abstract][Full Text] [Related]
19. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.
Koo BK; Kim D; Joo SK; Kim JH; Chang MS; Kim BG; Lee KL; Kim W
J Hepatol; 2017 Jan; 66(1):123-131. PubMed ID: 27599824
[TBL] [Abstract][Full Text] [Related]
20. Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART).
Bischoff J; Gu W; Schwarze-Zander C; Boesecke C; Wasmuth JC; van Bremen K; Dold L; Rockstroh JK; Trebicka J
EClinicalMedicine; 2021 Oct; 40():101116. PubMed ID: 34522873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
